STAT

article thumbnail

STAT+: Kennedy abruptly cancels preventive care committee meeting

STAT

WASHINGTON — Health secretary Robert F. Kennedy Jr. has abruptly canceled a meeting of a key expert panel that evaluates the nation’s preventive care recommendations, according to an email viewed by STAT. The email did not cite a reason.  The cancellation of the Thursday meeting of the U.S. Preventive Services Task Force comes just a couple of weeks after the U.S.

359
359
article thumbnail

STAT+: HHS backtracks on pledge to disclose new vaccine advisers’ conflicts of interest

STAT

WASHINGTON — The Department of Health and Human Services is sitting on information about new vaccine advisers’ conflicts of interest, and seemingly backtracking on its vow to make key disclosure documents public.  Agency officials previously said they would release ethics forms for seven new members of the Advisory Committee on Immunization Practices before the group’s first meeting in late June.

Vaccines 347
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: RFK Jr. says he has a team working on changes to the vaccine injury compensation program

STAT

WASHINGTON — Health secretary Robert F. Kennedy Jr. has assembled a team that he says will work on ways to expand a federal program aimed at compensating people who have been injured by vaccines, though his power to make big changes without congressional action is unclear. “We just brought a guy in this week who is going to be revolutionizing the [National] Vaccine Injury Compensation program,” Kennedy said in an interview with Tucker Carlson posted Monday.

Vaccines 298
article thumbnail

STAT+: Psychedelic therapy shows promise in mid-stage study in treatment-resistant depression

STAT

An experimental psychedelic therapy from the U.K. company Beckley Psytech significantly reduced symptoms of treatment-resistant depression in a mid-stage trial, newly released data show, raising expectations for a class of drugs racing toward potential approval by U.S. regulators.  Companies like Beckley, Atai Life Sciences, and Compass Pathways — the first two are in the process of merging — are now vying to bring psychedelic therapies to market at a time when the regulatory

article thumbnail

STAT+: AbbVie snaps up CAR-T company in a deal worth $2.1 billion

STAT

AbbVie said Monday that it would pay up to $2.1 billion to acquire Capstan Therapeutics , a startup developing CAR-T therapies for autoimmune conditions, fibrosis, and cancer.  AbbVie will pay up to $2.1 billion in cash when the deal closes, according to a press release. The companies did not give further details about the financial terms or a timeline for completing the acquisition.

242
242
article thumbnail

STAT+: New study challenges understanding of how age, chronic diseases and inflammation are linked

STAT

Reducing inflammation has become all the rage lately, with many medical experts pointing to anti-inflammatory diets and other lifestyle changes as ways people can reduce their risk of chronic disease as they age. But a new study suggests that inflammation’s effects on health are more complex than scientists previously understood.  In a study published in Nature Aging on Monday, researchers found that people living in non-industrialized societies experience less age-related chronic in

Diabetes 226
article thumbnail

STAT+: HHS to continue funding cancer prevention, tracking work in states after uncertainty

STAT

WASHINGTON — The Department of Health and Human Services will renew funding to states for cancer prevention and tracking efforts, alleviating anxieties among local officials about the future of their work.  Over 50 notices had gone out as of Monday, an HHS spokesperson said. The rest of the awards will be sent to states, tribes, and other contractors “no later than early next week,” press secretary Emily Hilliard told STAT in an email.

309
309